REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Vitafarma (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Full name: UAB Vitafarma Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Vitafarma is a company in Lithuania, with a head office in Kaunas. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. UAB Vitafarma was incorporated on July 26, 2002. UAB Vitafarma currently employs 14 (2025) people. In its most recent financial highlights, the company reported a net sales revenue increase of 31.64% in 2024. In 2024, UAB Vitafarma’s net profit margin increased by 0.02%.

Headquarters
Karmelavos sen. Biruliskiu k. Ryternos g. 5
Kaunas; Kaunas County; Postal Code: LT-54469

Contact Details: Purchase the UAB Vitafarma report to view the information.

Basic Information
Total Employees:
Purchase the UAB Vitafarma report to view the information.
Registered Capital:
Purchase the UAB Vitafarma report to view the information.
Financial Auditors:
Purchase the UAB Vitafarma report to view the information.
Incorporation Date:
July 26, 2002
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after UAB Vitafarma report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
31.64%
Total Operating Revenue
31.64%
Net Profit/Loss for the Period
32.89%
Total Equity
39.76%
Net Profit Margin
0.02%
Return on Equity (ROE)
-1.47%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?